Patents by Inventor Angel Morales

Angel Morales has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240165079
    Abstract: The present application provides a combination product for the treatment and/or prevention of psychiatric and/or neurological disorders. The combination product comprises (i) a compound which promotes neurogenesis and has hallucinogenic and/or psychedelic side effects, and (ii) a 5-HT2A receptor antagonist which alleviates and/or removes the hallucinogenic and/or psychedelic side effects caused by the first compound.
    Type: Application
    Filed: June 21, 2023
    Publication date: May 23, 2024
    Inventors: Ana Maria Perez Castillo, Jordi Riba Serrano, Jose Angel Morales Garcia
  • Patent number: 11794608
    Abstract: A third rail power insulating system, which has a cover board assembly having a support bracket assembly, cover board assembly retaining clips, a side cover board, and a top cover board. The support bracket assembly has a top wall, at least two pairs of top bracket holes with top threads, top bolt supports, a lateral wall, at least three pairs of lateral bracket holes with lateral threads, lateral bolt supports, internal walls, internal reinforcement walls, and a central wall. The side cover board has a plate having a plate top edge and a plate bottom edge, first and second lateral holes, and first and second lateral bolts. The top cover board has an elongated plate, a bottom face having hexagonal cells, first and second top holes, first and second top bolts, and an elongated lip.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: October 24, 2023
    Assignee: Eastern Rail Corp.
    Inventor: Miguel Angel Morales
  • Publication number: 20230330063
    Abstract: Combination product for the treatment of neurological and/or psychiatric disorders The present application provides a combination product for the treatment and/or prevention of psychiatric and/or neurological disorders. The combination product comprises (i) a compound which promotes neurogenesis and has hallucinogenic and/or psychedelic side effects, and (ii) a 5-HT2A receptor antagonist which alleviates and/or removes the hallucinogenic and/or psychedelic side effects caused by the first compound.
    Type: Application
    Filed: June 21, 2023
    Publication date: October 19, 2023
    Inventors: Ana Maria Perez Castillo, Jordi Riba Serrano, Jose Angel Morales Garcia
  • Patent number: 11723894
    Abstract: The present application provides a combination product for the treatment and/or prevention of psychiatric and/or neurological disorders. The combination product comprises (i) a compound which promotes neurogenesis and has hallucinogenic and/or psychedelic side effects, and (ii) a 5-HT2A receptor antagonist which alleviates and/or removes the hallucinogenic and/or psychedelic side effects caused by the first compound.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: August 15, 2023
    Assignee: TERRAN BIOSCIENCES, INC.
    Inventors: Ana Maria Perez Castillo, Jordi Riba Serrano, Jose Ángel Morales García
  • Publication number: 20230174541
    Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
    Type: Application
    Filed: September 2, 2022
    Publication date: June 8, 2023
    Inventors: Salvacion CACATIAN, David A. CLAREMON, Lawrence Wayne DILLARD, Chengguo DONG, Yi FAN, Lanqi JIA, Stephen D. LOTESTA, Andrew MARCUS, Angel MORALES-RAMOS, Suresh B. SINGH, Shankar VENKATRAMAN, Jing YUAN, Yajun ZHENG, Linghang ZHUANG, Stephan D. PARENT, Travis L. HOUSTON
  • Publication number: 20230175277
    Abstract: A system for reversibly converting stadiums into multifunctional infrastructure by removing the pitch and storing it in a pit (6), the pitch having a set of trays (1) having a total length equal to the pitch in a longitudinal direction of the pit, which are moveable, self-supporting and have layers of soil, irrigation and turf; a set of transport trolleys (2) for lifting and moving each tray (1) from its position on the pitch to the pit (6); a set of retractable trellises (5) that can be unfolded on the pit (6), for the entry of each tray (1) from above the pit; an elevator system (8) inside the pit (6) to move each tray to its final position, in storage, or on the pitch; and a storage system (7) for storing each tray in a fixed and stable position.
    Type: Application
    Filed: March 18, 2021
    Publication date: June 8, 2023
    Inventors: Juan Francisco PAZ PASCUAL, Jesus Maria LATA PEREZ, Xavier LEKUBE INSAUSTI, Jorge VIZCAYA PEREZ, Miguel Angel MORALES
  • Patent number: 11479557
    Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
    Type: Grant
    Filed: April 1, 2020
    Date of Patent: October 25, 2022
    Assignee: VITAE PHARMACEUTICALS, LLC
    Inventors: Salvacion Cacatian, David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Stephen D. Lotesta, Andrew Marcus, Angel Morales-Ramos, Suresh B. Singh, Shankar Venkatraman, Jing Yuan, Yajun Zheng, Linghang Zhuang, Stephan D. Parent, Travis L. Houston
  • Patent number: 11267367
    Abstract: A third rail insulator having a head assembly with a channel, and a pedestal assembly. The head assembly and the pedestal assembly are integrated as a single structure to support and isolate a contact rail assembly that supplies power to a transit vehicle. The channel is an open channel that diametrically extends along the upper section of the head assembly. The channel receives the contact rail assembly.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: March 8, 2022
    Inventor: Miguel Angel Morales
  • Publication number: 20210053974
    Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
    Type: Application
    Filed: April 1, 2020
    Publication date: February 25, 2021
    Applicant: VITAE PHARMACEUTICALS, LLC
    Inventors: Salvacion CACATIAN, David A. CLAREMON, Lawrence Wayne DILLARD, Chengguo DONG, Yi FAN, Lanqi JIA, Stephen D. LOTESTA, Andrew MARCUS, Angel MORALES-RAMOS, Suresh B. SINGH, Shankar VENKATRAMAN, Jing YUAN, Yajun ZHENG, Linghang ZHUANG, Stephan D. PARENT, Travis L. HOUSTON
  • Publication number: 20200397752
    Abstract: The present application provides a combination product for the treatment and/or prevention of psychiatric and/or neurological disorders. The combination product comprises (i) a compound which promotes neurogenesis and has hallucinogenic and/or psychedelic side effects, and (ii) a 5-HT2A receptor antagonist which alleviates and/or removes the hallucinogenic and/or psychedelic side effects caused by the first compound.
    Type: Application
    Filed: October 26, 2018
    Publication date: December 24, 2020
    Applicants: Consejo Superior de Investigacions Cientificas (CSIS), Universidad Autonoma de Madrid, Centro de Investigacion Biomedica en Red de Enformedadas Neurodegerativas, Blumentech, S.L., Institute de Recerca de L'Hospital de la Santa Creu I Sant Pau
    Inventors: Ana Maria Perez Castillo, Jordi Riba Serra-No, Jose Angel Morales Garcia
  • Patent number: 10683302
    Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: June 16, 2020
    Assignee: VITAE PHARMACEUTICALS, LLC
    Inventors: Salvacion Cacatian, David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Stephen D. Lotesta, Andrew Marcus, Angel Morales-Ramos, Suresh B. Singh, Shankar Venkatraman, Jing Yuan, Yajun Zheng, Linghang Zhuang, Stephan D. Parent, Travis L. Houston
  • Patent number: 10654884
    Abstract: Provided are novel purine nucleoside/nucleotide analogues compounds, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are inhibitors of CD73 and are useful in the treatment of cancer.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: May 19, 2020
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Salvacion Cacatian, David A. Claremon, Lanqi Jia, Angel Morales-Ramos, Suresh B. Singh, Shankar Venkatraman, Zhenrong Xu, Yajun Zheng
  • Patent number: 10658130
    Abstract: Systems and methods are disclosed herein relating to a momentary contact switch that can be both manually and electronically actuated. In some embodiments, an electronic module can be added to a manual momentary contact switch to enable electronic control. The momentary contact switch can be transitioned between first, second, and third electrical states based on the rotation of a shaft between first, second, and third rotational positions. Rotary arms are selectively engaged by pull arms connected to a master solenoid to selectively rotate the shaft from the first rotational position to the second and third rotational positions.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: May 19, 2020
    Assignee: Schweitzer Engineering Laboratories, Inc.
    Inventors: Carlos Baltazar Castro Maciel, Sergio David Esquivel Álvarez, José Ramón Martinez Ramírez, Héctor Jaime Alba, Eduardo Ángel Morales Delgado, Marco Antonio Hidrogo Ordaz, Gerardo Rodríguez Nájera
  • Patent number: 10637148
    Abstract: An apparatus includes a radio frequency (RF) feed and an extruded member made of metal and coupled to the RF feed. The extruded member includes a first surface that includes a first slot having a first width and a first length, and a second slot having a second width and a second length. The second width is at least 1.2 times greater than the first width. The second slot intersects the first slot at an angle with respect to the first slot that is between 70 and 110 degrees.
    Type: Grant
    Filed: January 18, 2018
    Date of Patent: April 28, 2020
    Assignee: Amazon Technologies, Inc.
    Inventors: Eswarappa Channabasappa, Anuj Dron, Adrian Napoles, Felipe Alonso Varela, Miguel Angel Morales
  • Publication number: 20190348230
    Abstract: Systems and methods are disclosed herein relating to a momentary contact switch that can be both manually and electronically actuated. In some embodiments, an electronic module can be added to a manual momentary contact switch to enable electronic control. The momentary contact switch can be transitioned between first, second, and third electrical states based on the rotation of a shaft between first, second, and third rotational positions. Rotary arms are selectively engaged by pull arms connected to a master solenoid to selectively rotate the shaft from the first rotational position to the second and third rotational positions.
    Type: Application
    Filed: May 10, 2018
    Publication date: November 14, 2019
    Applicant: Schweitzer Engineering Laboratories, Inc.
    Inventors: Carlos Baltazar Castro Maciel, Sergio David Esquivel Álvarez, José Ramón Martinez Ramírez, Héctor Jaime Alba, Eduardo Ángel Morales Delgado, Marco Antonio Hidrogo Ordaz, Gerardo Rodríguez Nájera
  • Patent number: 10336717
    Abstract: The present invention is directed to a compound represented by the following structural formula or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also described.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: July 2, 2019
    Assignee: Vitae Pharmaceuticals, LLC
    Inventors: Salvacion Cacatian, David A. Claremon, Lawrence Wayne Dillard, Klaus Fuchs, Niklas Heine, Lanqi Jia, Katerina Leftheris, Brian McKeever, Angel Morales-Ramos, Suresh B. Singh, Shankar Venkatraman, Guosheng Wu, Zhongren Wu, Zhenrong Xu, Jing Yuan, Yajun Zheng
  • Publication number: 20190144459
    Abstract: The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
    Type: Application
    Filed: June 8, 2017
    Publication date: May 16, 2019
    Inventors: Salvacion Cacatian, David A. Claremon, Lawrence Wayne Dillard, Chengguo Dong, Yi Fan, Lanqi Jia, Stephen D. Lotesta, Andrew Marcus, Angel Morales-Ramos, Suresh B. Singh, Shankar Venkatraman, Jing Yuan, Yajun Zheng, Linghang Zhuang, Stephan D. Parent, Travis L. Houston
  • Publication number: 20180344734
    Abstract: The present invention relates to spirocyclic acylguanidines and their use as inhibitors of the ?-secretase enzyme (BACE1) activity, pharmaceutical compositions containing the same, and methods of using the same as therapeutic agents in the treatment of neurodegenerative disorders, disorders characterized by cognitive decline, cognitive impairment, dementia and diseases characterized by production of ?-amyloid aggregates.
    Type: Application
    Filed: March 12, 2018
    Publication date: December 6, 2018
    Inventors: Yuri Bukhtiyarov, Salvacion Cacatian, Lawrence Wayne Dillard, Cornelia Dorner-Ciossek, Klaus Fuchs, Lanqi Jia, Deepak S. Lala, Angel Morales-Ramos, Jonathan Reeves, Suresch B. Singh, Shankar Venkatraman, Zhenrong Xu, Jing Yuan, Yi Zhao, Yajun Zheng, Georg Rast
  • Patent number: D897897
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: October 6, 2020
    Inventor: Miguel Angel Morales
  • Patent number: D917069
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: April 20, 2021
    Inventor: Miguel Angel Morales